Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

Clinical trial NCT05232630 · UNKNOWN

Trial details

NCT number: NCT05232630
Sponsor: Hospital Ruber Internacional
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Refractory Epilepsy SYNGAP1 Encephalopathy STXBP1 Encephalopathy With Epilepsy Inv Dup(15) Encephalopathy Multifocal or Bilateral Malformations of Cortical Development Continuous Spike and Waves During Slow Sleep

Start date: 2022-10-20
Primary completion: 2025-02-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.